Clinical Trials on First-degree Relative With Breast Cancer
Total 1258 results
-
Nova Scotia Health AuthorityObafemi Awolowo UniversityNot yet recruitingTriple Negative Breast Cancer
-
University of Alabama at BirminghamNot yet recruitingTriple Negative Breast CancerUnited States
-
Sun Yat-sen UniversityRecruitingTriple Negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
University of Illinois at ChicagoRecruitingTriple Negative Breast CancerUnited States
-
Shengjing HospitalRecruiting
-
European Institute of OncologyRecruitingTriple Negative Breast CancerItaly
-
Zenith EpigeneticsPfizer; Newsoara Biopharma Co., Ltd.TerminatedTriple Negative Breast CancerUnited States, Belgium, China, Spain
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Ayala Pharmaceuticals, Inc,TerminatedTriple Negative Breast CancerUnited States, Belgium, Israel, Spain, United Kingdom
-
Jeong Eon LeeAsan Medical Center; Seoul National University Hospital; Gangnam Severance Hospital and other collaboratorsActive, not recruiting
-
Fudan UniversityActive, not recruitingTA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA SignatureBreast Cancer | Triple Negative Breast CancerChina
-
Tata Memorial HospitalActive, not recruiting
-
Hoffmann-La RocheBreast International Group; Frontier Science & Technology Research Foundation... and other collaboratorsCompletedTriple Negative Breast CancerRussian Federation, United States, Israel, Italy, Spain, France, Korea, Republic of, United Kingdom, Denmark, Taiwan, Hungary, Argentina, Australia, Austria, Belgium, Brazil, China, Germany, Hong Kong, Japan, Mexico, Romania, Switze... and more
-
Baylor Research InstituteEli Lilly and CompanyCompletedTriple Negative Breast CancerUnited States
-
Joyce O'ShaughnessyTakedaCompletedTriple Negative Breast CancerUnited States
-
Indiana UniversityCompletedTriple Negative Breast CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaTrans Tasman Radiation Oncology GroupCompleted
-
Providence Health & ServicesMerck Sharp & Dohme LLC; Brooklyn ImmunoTherapeutics, LLCActive, not recruitingBreast Cancer | Breast NeoplasmsUnited States
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedBreast Cancer | Triple Negative Breast CancerChina
-
NYU Langone HealthNational Institutes of Health (NIH)TerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
Queen Mary University of LondonHoffmann-La Roche; MedSIR; Westdeutsche Studiengruppe GmbH (WSG)Active, not recruitingTriple Negative Breast CancerUnited Kingdom
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySuspended
-
SanofiTerminatedTriple Negative Breast CancerSpain, Belgium, Italy, Czechia, Netherlands
-
Marker Therapeutics, Inc.CompletedBreast CancerUnited States
-
Hebei Medical University Fourth HospitalWithdrawnTriple Negative Breast CancerChina
-
Leo W. Jenkins Cancer CenterTerminatedBreast CancerUnited States
-
University of Wisconsin, MadisonActive, not recruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
German Breast GroupAstraZeneca; CelgeneCompleted
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Fudan UniversityCompleted
-
AbbVieTerminated
-
Mario Negri Institute for Pharmacological ResearchAssociazione Italiana per la Ricerca sul CancroTerminated
-
University of VirginiaCelldex TherapeuticsWithdrawn
-
Hoffmann-La RocheCompletedBreast CancerUnited Kingdom
-
Genentech, Inc.Hoffmann-La RocheCompletedBreast CancerUnited States, Belgium, France, Germany, United Kingdom, Spain
-
Jules Bordet InstituteWithdrawnBreast CancerBelgium, France
-
National Taiwan University HospitalUnknownTriple Negative Breast CancerTaiwan
-
Istituti Ospitalieri di CremonaUnknownBreast Cancer | Triple Negative Breast Cancer
-
Istituti Ospitalieri di CremonaUnknownSafety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast CancersTriple Negative Breast CancerItaly
-
Cancer Institute and Hospital, Chinese Academy...Beijing Municipal Science & Technology CommissionActive, not recruitingTriple Negative Breast Cancer
-
Fudan UniversityZhejiang Cancer Hospital; Changhai Hospital; 307 Hospital of PLA; Sun Yat-sen University and other collaboratorsCompleted
-
Institut Paoli-CalmettesUnknown
-
Asan Medical CenterCompletedBreast CancerKorea, Republic of
-
Russian Academy of Medical SciencesCompletedInduction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast CancerTriple Negative Breast CancerRussian Federation
-
Piramal Enterprises LimitedTerminated
-
Dana-Farber Cancer InstituteWithdrawnBreast Cancer | Breast Neoplasms | Breast Carcinoma | Triple Negative Breast Cancer | Breast Cancer Stage II | Breast Cancer Stage III | Early Stage Triple-Negative Breast CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast CancerUnited States